Lead Discovery: The Process

Lead Generation Approaches in Drug Discovery

Volumn , Issue , 2010, Pages 1-19

  Michne, William F ^a  

^a Medorion Inc   (United States)

Author keywords

Biology based libraries; Hit to lead process lead compound discovery, milestone to new small molecule drug discovery; Lead discovery and molecular complexity

Indexed keywords

EID: 84885991093     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470584170.ch1     Document Type: Chapter

References (26)

1. Michne, W. F. (1996). Hit-to-lead chemistry: a key element in new lead generation. Pharmaceutical News, 3, 19-21.
2. Davis, A. M., Keeling, D. J., Steele, J., Tomkinson, N. P., Tinker, A. C. (2005). Components of successful lead generation. Current Topics in Medicinal Chemistry, 5, 421-439.
3. Bohacek, R. S., McMartin, C., Guida, W. C. (1996). The art and practice of structure-based drug design: a molecular modeling perspective. Medicinal Research Reviews, 16, 3-50.
4. Lipinski, C. A., Lombardo, F., Dominy, B. W., Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3-25.
5. Veber, D. F., Johnson, S. R., Cheng, H., Smith, B. R., Ward, K. W., Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45, 2615-2623.
6. Lu, J. J., Crimin, K., Goodwin, J. T., Crivori, P., Orrenius, C., Xing, L., Tandler, P. J., Vidmar, T. J., Amore, B. M., Wilson, A. G. E., Stouten, P. F.W., Burton, P. S. (2004). Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. Journal of Medicinal Chemistry, 47, 6104-6107.
7. Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., Leeson, P. D. (2003). A comparison of physiochemical property profiles of development and marketed drugs. Journal of Medicinal Chemistry, 46, 1250-1256.
8. Leeson, P. D., Springthorpe, B. (2007). The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery, 6, 881-890.
9. Bemis, G. W., Murcko, M. A. (1996). The properties of known drugs. 1. Molecular frameworks. Journal of Medicinal Chemistry, 39, 2887-2893.
10. Bemis, G. W., Murcko, M. A. (1999). The properties of known drugs. 2. Side chains. Journal of Medicinal Chemistry, 42, 5095-5099.
11. Ajay, Bemis, G. W., Murcko, M. A. (1999). Designing libraries with CNS activity. Journal of Medicinal Chemistry, 42, 4942-4951.
12. Jacoby, E., Schuffenhauer, A., Popov, M., Azzaoui, K., Havill, B., Schopfer, U., Engeloch, C., Stanek, J., Acklin, P., Rigollier, P., Stoll, F., Koch, G., Meier, P., Orain, D., Giger, R., Hinrichs, J., Malagu, K., Zimmermann, J., Roth, H. (2005). Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection. Current Topics in Medicinal Chemistry, 5, 397-411.
13. Lajiness, M. S., Maggiora, G. M., Shanmugasundaram, V. (2004). Assessment of the consistency of medicinal chemists in reviewing sets of compounds. Journal of Medicinal Chemistry, 47, 4891-4896.
14. Bertz, S. H. (1981). The first general index of molecular complexity. Journal of the American Chemical Society, 103, 3599-3601.
15. Whitlock, H. W. (1998). On the structure of total syntheses of complex natural products. Journal of Organic Chemistry, 63, 7982-7989.
16. Barone, R., Chanon, M. (2001). A new and simple approach to chemical complexity. Application to the synthesis of natural products. Journal of Chemical Information and Computer Sciences, 41, 269-272.
17. Bentley, K. W., Hardy, D. G. (1967). Novel analgesics and molecular rearrangements in the morphine-thebaine group. I. Ketones derived from 6, 14-endo-ethenotetrahydrothebaine. Journal of the American Chemical Society, 89, 3267-3273.
18. Tan, D. S., Foley, M. A., Stockwell, B. R., Shair, M. D., Schreiber, S. L. (1999). Synthesis and preliminary evaluation of a library of polycyclic small molecules for use in chemical genetics assays. Journal of the American Chemical Society, 121, 9073-9087.
19. Hann, M. M., Leach, A. R., Harper, G. (2001). Molecular complexity and its impact on the probability of finding leads for drug discovery. Journal of Chemical Information and Computer Sciences, 41, 856-864.
20. Schuffenhauer, A., Brown, N., Selzer, P., Ertl, P., Jacoby, E. (2006). Relationships between molecular complexity, biological activity, and structural diversity. Journal of Chemical Information and Modeling, 46, 525-535.
21. Martin, Y. C., Kofron, J. L., Traphagen, L. M. (2002). Do structurally similar molecules have similar biological activity? Journal of Medicinal Chemistry, 45, 4350-4358.
22. Bostrom, J., Hogner, A., Schmitt, S. (2006). Do structurally similar ligands bind in a similar manner? Journal of Medicinal Chemistry, 49, 6716-6725.
23. Beroza, P., Damodaran, K., Lum, R. T. (2005). Target-related affinity profiling: Telik's lead discovery technology. Current Topics in Medicinal Chemistry, 5, 371-381.
24. Baxter, A., Bennion, C., Bent, J., Boden, K., Brough, S., Cooper, A., Kinchin, E., Kindon, N., McInally, T., Mortimore, M., Roberts, B., Unitt, J. (2003). Hit-to-lead studies: the discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists. Bioorganic and Medicinal Chemistry Letters, 13, 2625-2628.
25. Baxter, A., Brough, S., Cooper, A., Floettmann, E., Foster, S., Harding, C., Kettle, J., McInally, T., Martin, C., Mobbs, M., Needham, M., Newham, P., Paine, S., St- Gallay, S., Salter, S., Unitt, J., Xue, Y. (2004). Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. Bioorganic and Medicinal Chemistry Letters, 14, 2817-2822.
26. Baxter, A., Cooper, A., Kinchin, E., Moakes, K., Unitt, J., Wallace, A. (2006). Hitto- lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists. Bioorganic and Medicinal Chemistry Letters, 16, 960-963.